CD8A and neoplasm: Importantly, we (Fu et al. 2024) also reveal that while GSK-3β deficiency in DCs enhances early/primary CD8 T-cell responses, it impairs the ability to support the generation and/or maintenance of memory CD8 T cells (Figure 2), which are crucial for long-term immune protection against tumor recurrence.